<tbody><tr role="row" class="odd"><td class=" colTicker col1">CELG</td><td class=" colIssueName col2">CELGENE CORP</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">8.09</td><td class=" colNotionalValue col8">811,875,559.50</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">AMGN</td><td class=" colIssueName col2">AMGEN INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">7.77</td><td class=" colNotionalValue col8">779,667,271.50</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">BIIB</td><td class=" colIssueName col2">BIOGEN INC INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">7.75</td><td class=" colNotionalValue col8">777,033,129.91</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">GILD</td><td class=" colIssueName col2">GILEAD SCIENCES INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">7.55</td><td class=" colNotionalValue col8">757,458,473.28</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">REGN</td><td class=" colIssueName col2">REGENERON PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">5.33</td><td class=" colNotionalValue col8">534,663,256.08</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">VRTX</td><td class=" colIssueName col2">VERTEX PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">4.08</td><td class=" colNotionalValue col8">409,380,302.43</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">ILMN</td><td class=" colIssueName col2">ILLUMINA INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">3.68</td><td class=" colNotionalValue col8">369,493,393.28</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">ALXN</td><td class=" colIssueName col2">ALEXION PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">3.64</td><td class=" colNotionalValue col8">365,542,536.52</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">MYL</td><td class=" colIssueName col2">MYLAN NV</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">3.05</td><td class=" colNotionalValue col8">305,511,651.90</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">INCY</td><td class=" colIssueName col2">INCYTE CORP</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">2.73</td><td class=" colNotionalValue col8">273,859,443.48</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">BMRN</td><td class=" colIssueName col2">BIOMARIN PHARMACEUTICAL INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">2.16</td><td class=" colNotionalValue col8">216,192,007.20</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">ALNY</td><td class=" colIssueName col2">ALNYLAM PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">1.75</td><td class=" colNotionalValue col8">175,242,018.68</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">SHPG</td><td class=" colIssueName col2">SHIRE ADR REPRESENTING  PLC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">1.57</td><td class=" colNotionalValue col8">157,763,985.09</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">NKTR</td><td class=" colIssueName col2">NEKTAR THERAPEUTICS</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">1.29</td><td class=" colNotionalValue col8">129,615,986.50</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">EXEL</td><td class=" colIssueName col2">EXELIXIS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">1.24</td><td class=" colNotionalValue col8">124,499,343.21</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">ALKS</td><td class=" colIssueName col2">ALKERMES</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">1.16</td><td class=" colNotionalValue col8">115,886,127.15</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">BLUE</td><td class=" colIssueName col2">BLUEBIRD BIO INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">1.12</td><td class=" colNotionalValue col8">112,051,575.60</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">JAZZ</td><td class=" colIssueName col2">JAZZ PHARMACEUTICALS PLC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">1.11</td><td class=" colNotionalValue col8">111,394,686.20</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">SGEN</td><td class=" colIssueName col2">SEATTLE GENETICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">1.07</td><td class=" colNotionalValue col8">107,779,878.40</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">QGEN</td><td class=" colIssueName col2">QIAGEN NV</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.96</td><td class=" colNotionalValue col8">96,556,131.81</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">SAGE</td><td class=" colIssueName col2">SAGE THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.94</td><td class=" colNotionalValue col8">94,104,921.31</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">NBIX</td><td class=" colIssueName col2">NEUROCRINE BIOSCIENCES INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.90</td><td class=" colNotionalValue col8">90,768,278.37</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">UTHR</td><td class=" colIssueName col2">UNITED THERAPEUTICS CORP</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.87</td><td class=" colNotionalValue col8">87,737,748.28</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">IONS</td><td class=" colIssueName col2">IONIS PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.86</td><td class=" colNotionalValue col8">86,117,690.88</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">BIVV</td><td class=" colIssueName col2">BIOVERATIV INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.79</td><td class=" colNotionalValue col8">79,554,860.32</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">PRAH</td><td class=" colIssueName col2">PRA HEALTH SCIENCES INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.78</td><td class=" colNotionalValue col8">78,510,110.80</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">JUNO</td><td class=" colIssueName col2">JUNO THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.73</td><td class=" colNotionalValue col8">73,640,862.57</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">TECH</td><td class=" colIssueName col2">BIO TECHNE CORP</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.65</td><td class=" colNotionalValue col8">65,627,298.12</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">TSRO</td><td class=" colIssueName col2">TESARO INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.62</td><td class=" colNotionalValue col8">62,120,072.92</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">INCR</td><td class=" colIssueName col2">INC RESEARCH HOLDINGS INC CLASS A</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.62</td><td class=" colNotionalValue col8">62,038,792.40</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">FGEN</td><td class=" colIssueName col2">FIBROGEN INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.54</td><td class=" colNotionalValue col8">54,390,765.00</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">ACAD</td><td class=" colIssueName col2">ACADIA PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.53</td><td class=" colNotionalValue col8">52,792,198.74</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">PBYI</td><td class=" colIssueName col2">PUMA BIOTECHNOLOGY INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.50</td><td class=" colNotionalValue col8">50,549,298.80</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">AVXS</td><td class=" colIssueName col2">AVEXIS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.50</td><td class=" colNotionalValue col8">49,940,410.80</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">SRPT</td><td class=" colIssueName col2">SAREPTA THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.50</td><td class=" colNotionalValue col8">49,778,701.47</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">CLVS</td><td class=" colIssueName col2">CLOVIS ONCOLOGY INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.45</td><td class=" colNotionalValue col8">45,387,811.68</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">GRFS</td><td class=" colIssueName col2">GRIFOLS ADR REPRESENTING ONE NON-V</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.45</td><td class=" colNotionalValue col8">44,825,081.25</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">GWPH</td><td class=" colIssueName col2">GW PHARMACEUTICALS ADR REPRESENTIN</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.43</td><td class=" colNotionalValue col8">43,474,952.20</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">PTLA</td><td class=" colIssueName col2">PORTOLA PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.42</td><td class=" colNotionalValue col8">41,941,746.00</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">BPMC</td><td class=" colIssueName col2">BLUEPRINT MEDICINES CORP</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.41</td><td class=" colNotionalValue col8">41,321,885.76</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">AGIO</td><td class=" colIssueName col2">AGIOS PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.40</td><td class=" colNotionalValue col8">40,292,416.64</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">HALO</td><td class=" colIssueName col2">HALOZYME THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.40</td><td class=" colNotionalValue col8">40,194,340.78</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">LGND</td><td class=" colIssueName col2">LIGAND PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.40</td><td class=" colNotionalValue col8">39,897,196.44</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">OPK</td><td class=" colIssueName col2">OPKO HEALTH INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.38</td><td class=" colNotionalValue col8">37,753,466.85</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">LOXO</td><td class=" colIssueName col2">LOXO ONCOLOGY INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.35</td><td class=" colNotionalValue col8">35,281,091.08</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">ARRY</td><td class=" colIssueName col2">ARRAY BIOPHARMA INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.35</td><td class=" colNotionalValue col8">34,839,560.05</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">BGNE</td><td class=" colIssueName col2">BEIGENE ADR REPRESENTING LTD</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.34</td><td class=" colNotionalValue col8">34,595,063.20</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">FMI</td><td class=" colIssueName col2">FOUNDATION MEDICINE INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.34</td><td class=" colNotionalValue col8">34,028,355.15</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">IMMU</td><td class=" colIssueName col2">IMMUNOMEDICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.34</td><td class=" colNotionalValue col8">33,823,885.44</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">HZNP</td><td class=" colIssueName col2">HORIZON PHARMA PLC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.33</td><td class=" colNotionalValue col8">33,380,710.92</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">FOLD</td><td class=" colIssueName col2">AMICUS THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.33</td><td class=" colNotionalValue col8">33,274,612.84</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">INSM</td><td class=" colIssueName col2">INSMED INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.33</td><td class=" colNotionalValue col8">32,788,916.20</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">MYGN</td><td class=" colIssueName col2">MYRIAD GENETICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.33</td><td class=" colNotionalValue col8">32,649,916.08</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">ANAB</td><td class=" colIssueName col2">ANAPTYSBIO INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.32</td><td class=" colNotionalValue col8">31,821,526.58</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">AERI</td><td class=" colIssueName col2">AERIE PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.31</td><td class=" colNotionalValue col8">30,998,726.85</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">CBPO</td><td class=" colIssueName col2">CHINA BIOLOGIC PRODUCTS HOLDINGS I</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.30</td><td class=" colNotionalValue col8">29,768,052.38</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">SUPN</td><td class=" colIssueName col2">SUPERNUS PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.28</td><td class=" colNotionalValue col8">28,511,203.20</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">IRWD</td><td class=" colIssueName col2">IRONWOOD PHARMA INC CLASS A</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.28</td><td class=" colNotionalValue col8">28,352,378.88</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">MDCO</td><td class=" colIssueName col2">MEDICINES</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.27</td><td class=" colNotionalValue col8">27,469,820.52</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">RARE</td><td class=" colIssueName col2">ULTRAGENYX PHARMACEUTICAL INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.27</td><td class=" colNotionalValue col8">27,272,660.80</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">AIMT</td><td class=" colIssueName col2">AIMMUNE THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.27</td><td class=" colNotionalValue col8">26,891,137.84</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">XLRN</td><td class=" colIssueName col2">ACCELERON PHARMA INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.27</td><td class=" colNotionalValue col8">26,691,575.04</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">ONCE</td><td class=" colIssueName col2">SPARK THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.26</td><td class=" colNotionalValue col8">26,282,522.30</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">SPPI</td><td class=" colIssueName col2">SPECTRUM PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.26</td><td class=" colNotionalValue col8">26,194,255.70</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">PCRX</td><td class=" colIssueName col2">PACIRA PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.25</td><td class=" colNotionalValue col8">25,138,076.85</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">NVCR</td><td class=" colIssueName col2">NOVOCURE LTD</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.25</td><td class=" colNotionalValue col8">24,975,109.00</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">GBT</td><td class=" colIssueName col2">GLOBAL BLOOD THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.24</td><td class=" colNotionalValue col8">24,249,589.10</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">ESPR</td><td class=" colIssueName col2">ESPERION THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.24</td><td class=" colNotionalValue col8">24,079,522.72</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">ENDP</td><td class=" colIssueName col2">ENDO INTERNATIONAL PLC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.24</td><td class=" colNotionalValue col8">23,839,124.04</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">ICPT</td><td class=" colIssueName col2">INTERCEPT PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.21</td><td class=" colNotionalValue col8">21,462,497.50</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">RGEN</td><td class=" colIssueName col2">REPLIGEN CORP</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.21</td><td class=" colNotionalValue col8">21,430,437.60</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">INVA</td><td class=" colIssueName col2">INNOVIVA INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.21</td><td class=" colNotionalValue col8">21,046,926.47</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">TBPH</td><td class=" colIssueName col2">THERAVANCE BIOPHARMA INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.21</td><td class=" colNotionalValue col8">20,970,167.01</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">MYOK</td><td class=" colIssueName col2">MYOKARDIA INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.20</td><td class=" colNotionalValue col8">20,428,327.15</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">PRTA</td><td class=" colIssueName col2">PROTHENA PLC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.20</td><td class=" colNotionalValue col8">19,917,282.00</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">ZGNX</td><td class=" colIssueName col2">ZOGENIX INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.20</td><td class=" colNotionalValue col8">19,691,786.00</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">SGMO</td><td class=" colIssueName col2">SANGAMO THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.20</td><td class=" colNotionalValue col8">19,645,794.30</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">RDUS</td><td class=" colIssueName col2">RADIUS HEALTH INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.19</td><td class=" colNotionalValue col8">19,158,202.72</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">BLKFDS</td><td class=" colIssueName col2">BLK CSH FND TREASURY SL AGENCY</td><td class=" colAssetClass col3">Money Market</td><td class=" colHoldingPercent col4">0.19</td><td class=" colNotionalValue col8">19,136,176.40</td><td class=" colSectorName col9">Cash and/or Derivatives</td></tr><tr role="row" class="even"><td class=" colTicker col1">ARNA</td><td class=" colIssueName col2">ARENA PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.18</td><td class=" colNotionalValue col8">18,542,584.16</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">MEDP</td><td class=" colIssueName col2">MEDPACE HOLDINGS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.18</td><td class=" colNotionalValue col8">18,540,070.90</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">EDIT</td><td class=" colIssueName col2">EDITAS MEDICINE INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.18</td><td class=" colNotionalValue col8">17,994,644.50</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">ASND</td><td class=" colIssueName col2">ASCENDIS PHARMA ADR REPRESENTING</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.17</td><td class=" colNotionalValue col8">17,450,822.70</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">TXMD</td><td class=" colIssueName col2">THERAPEUTICSMD INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.17</td><td class=" colNotionalValue col8">17,321,180.13</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">GHDX</td><td class=" colIssueName col2">GENOMIC HEALTH INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.17</td><td class=" colNotionalValue col8">16,631,631.87</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">AKCA</td><td class=" colIssueName col2">AKCEA THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.17</td><td class=" colNotionalValue col8">16,568,838.00</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">DERM</td><td class=" colIssueName col2">DERMIRA INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.16</td><td class=" colNotionalValue col8">15,926,141.46</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">ENTA</td><td class=" colIssueName col2">ENANTA PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.15</td><td class=" colNotionalValue col8">15,452,526.75</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">RVNC</td><td class=" colIssueName col2">REVANCE THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.15</td><td class=" colNotionalValue col8">15,308,871.60</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">LXRX</td><td class=" colIssueName col2">LEXICON PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.15</td><td class=" colNotionalValue col8">15,043,694.60</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">AMRN</td><td class=" colIssueName col2">AMARIN ADR REPRESENTING  PLC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.15</td><td class=" colNotionalValue col8">14,840,710.65</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">RGNX</td><td class=" colIssueName col2">REGENXBIO INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.14</td><td class=" colNotionalValue col8">14,521,456.80</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">XNCR</td><td class=" colIssueName col2">XENCOR INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.14</td><td class=" colNotionalValue col8">14,444,355.84</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">ACOR</td><td class=" colIssueName col2">ACORDA THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.14</td><td class=" colNotionalValue col8">14,372,400.35</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">MNTA</td><td class=" colIssueName col2">MOMENTA PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.14</td><td class=" colNotionalValue col8">14,319,717.50</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">GLPG</td><td class=" colIssueName col2">GALAPAGOS ADR REPRESENTING NV</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.14</td><td class=" colNotionalValue col8">13,944,022.68</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">FLXN</td><td class=" colIssueName col2">FLEXION THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.13</td><td class=" colNotionalValue col8">13,241,249.06</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">BOLD</td><td class=" colIssueName col2">AUDENTES THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.13</td><td class=" colNotionalValue col8">12,946,661.52</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">OMER</td><td class=" colIssueName col2">OMEROS CORP</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.13</td><td class=" colNotionalValue col8">12,807,527.79</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">ATNX</td><td class=" colIssueName col2">ATHENEX INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.13</td><td class=" colNotionalValue col8">12,750,150.42</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">AMPH</td><td class=" colIssueName col2">AMPHASTAR PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.12</td><td class=" colNotionalValue col8">12,373,940.04</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">EPZM</td><td class=" colIssueName col2">EPIZYME INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.12</td><td class=" colNotionalValue col8">12,279,956.00</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">IMGN</td><td class=" colIssueName col2">IMMUNOGEN INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.12</td><td class=" colNotionalValue col8">11,922,918.24</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">LMNX</td><td class=" colIssueName col2">LUMINEX CORP</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.12</td><td class=" colNotionalValue col8">11,880,441.62</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">NTLA</td><td class=" colIssueName col2">INTELLIA THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.12</td><td class=" colNotionalValue col8">11,769,291.51</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">CRSP</td><td class=" colIssueName col2">CRISPR THERAPEUTICS AG</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.12</td><td class=" colNotionalValue col8">11,764,255.00</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">RTRX</td><td class=" colIssueName col2">RETROPHIN INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.12</td><td class=" colNotionalValue col8">11,658,311.68</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">CTMX</td><td class=" colIssueName col2">CYTOMX THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.11</td><td class=" colNotionalValue col8">11,440,094.85</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">SCMP</td><td class=" colIssueName col2">SUCAMPO PHARMACEUTICALS INC CLASS</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.11</td><td class=" colNotionalValue col8">11,429,691.35</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">ITCI</td><td class=" colIssueName col2">INTRA CELLULAR THERAPIES INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.11</td><td class=" colNotionalValue col8">11,299,962.52</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">EGRX</td><td class=" colIssueName col2">EAGLE PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.11</td><td class=" colNotionalValue col8">11,138,987.86</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">ADMS</td><td class=" colIssueName col2">ADAMAS PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.11</td><td class=" colNotionalValue col8">10,920,566.36</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">ALDR</td><td class=" colIssueName col2">ALDER BIOPHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.11</td><td class=" colNotionalValue col8">10,577,968.00</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">ACRS</td><td class=" colIssueName col2">ACLARIS THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.10</td><td class=" colNotionalValue col8">10,461,709.32</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">ANIP</td><td class=" colIssueName col2">ANI PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.10</td><td class=" colNotionalValue col8">10,097,196.96</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">AKBA</td><td class=" colIssueName col2">AKEBIA THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.10</td><td class=" colNotionalValue col8">9,963,150.62</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">DOVA</td><td class=" colIssueName col2">DOVA PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.10</td><td class=" colNotionalValue col8">9,894,624.64</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">MGNX</td><td class=" colIssueName col2">MACROGENICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.10</td><td class=" colNotionalValue col8">9,729,186.36</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">PTCT</td><td class=" colIssueName col2">PTC THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.09</td><td class=" colNotionalValue col8">9,451,994.79</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">VNDA</td><td class=" colIssueName col2">VANDA PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.09</td><td class=" colNotionalValue col8">9,402,212.70</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">FPRX</td><td class=" colIssueName col2">FIVE PRIME THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.09</td><td class=" colNotionalValue col8">8,878,754.36</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">INSY</td><td class=" colIssueName col2">INSYS THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.09</td><td class=" colNotionalValue col8">8,616,310.64</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">CLXT</td><td class=" colIssueName col2">CALYXT INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.08</td><td class=" colNotionalValue col8">8,487,748.95</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">COLL</td><td class=" colIssueName col2">COLLEGIUM PHARMACEUTICAL INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.08</td><td class=" colNotionalValue col8">8,453,376.84</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">IOVA</td><td class=" colIssueName col2">IOVANCE BIOTHERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.08</td><td class=" colNotionalValue col8">8,218,294.80</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">QURE</td><td class=" colIssueName col2">UNIQURE NV</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.08</td><td class=" colNotionalValue col8">8,056,072.20</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">ADRO</td><td class=" colIssueName col2">ADURO BIOTECH INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.08</td><td class=" colNotionalValue col8">7,954,423.30</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">CNCE</td><td class=" colIssueName col2">CONCERT PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.08</td><td class=" colNotionalValue col8">7,947,941.70</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">GLYC</td><td class=" colIssueName col2">GLYCOMIMETICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.08</td><td class=" colNotionalValue col8">7,887,510.52</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">DBVT</td><td class=" colIssueName col2">DBV TECHNOLOGIES ADR REPRESENTING</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.08</td><td class=" colNotionalValue col8">7,869,025.15</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">SGYP</td><td class=" colIssueName col2">SYNERGY PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.08</td><td class=" colNotionalValue col8">7,727,749.30</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">AXON</td><td class=" colIssueName col2">AXOVANT SCIENCES LTD</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.08</td><td class=" colNotionalValue col8">7,704,440.40</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">RIGL</td><td class=" colIssueName col2">RIGEL PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.08</td><td class=" colNotionalValue col8">7,547,771.70</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">GTHX</td><td class=" colIssueName col2">G1 THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.07</td><td class=" colNotionalValue col8">7,478,637.45</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">VYGR</td><td class=" colIssueName col2">VOYAGER THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.07</td><td class=" colNotionalValue col8">7,353,075.84</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">RETA</td><td class=" colIssueName col2">REATA PHARMACEUTICALS INC CLASS A</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.07</td><td class=" colNotionalValue col8">7,219,564.48</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">DEPO</td><td class=" colIssueName col2">DEPOMED INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.07</td><td class=" colNotionalValue col8">7,138,680.57</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">CHRS</td><td class=" colIssueName col2">COHERUS BIOSCIENCES INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.07</td><td class=" colNotionalValue col8">7,070,428.40</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">PRTK</td><td class=" colIssueName col2">PARATEK PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.07</td><td class=" colNotionalValue col8">6,913,226.10</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">BCRX</td><td class=" colIssueName col2">BIOCRYST PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.07</td><td class=" colNotionalValue col8">6,829,161.38</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">KURA</td><td class=" colIssueName col2">KURA ONCOLOGY INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.07</td><td class=" colNotionalValue col8">6,524,720.00</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">AMAG</td><td class=" colIssueName col2">AMAG PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.06</td><td class=" colNotionalValue col8">6,487,163.65</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">ATRA</td><td class=" colIssueName col2">ATARA BIOTHERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.06</td><td class=" colNotionalValue col8">6,361,873.00</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">AKAO</td><td class=" colIssueName col2">ACHAOGEN INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.06</td><td class=" colNotionalValue col8">6,305,192.18</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">KPTI</td><td class=" colIssueName col2">KARYOPHARM THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.06</td><td class=" colNotionalValue col8">6,296,976.95</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">KALA</td><td class=" colIssueName col2">KALA PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.06</td><td class=" colNotionalValue col8">6,287,765.00</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">CYTK</td><td class=" colIssueName col2">CYTOKINETICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.06</td><td class=" colNotionalValue col8">6,244,151.00</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">SVRA</td><td class=" colIssueName col2">SAVARA INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.06</td><td class=" colNotionalValue col8">6,145,859.85</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">PDLI</td><td class=" colIssueName col2">PDL BIOPHARMA INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.06</td><td class=" colNotionalValue col8">6,080,886.57</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">MCRB</td><td class=" colIssueName col2">SERES THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.06</td><td class=" colNotionalValue col8">5,697,470.96</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">JNCE</td><td class=" colIssueName col2">JOUNCE THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.06</td><td class=" colNotionalValue col8">5,679,203.40</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">CARA</td><td class=" colIssueName col2">CARA THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.06</td><td class=" colNotionalValue col8">5,615,663.24</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">PGNX</td><td class=" colIssueName col2">PROGENICS PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.06</td><td class=" colNotionalValue col8">5,604,943.50</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">NVAX</td><td class=" colIssueName col2">NOVAVAX INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.06</td><td class=" colNotionalValue col8">5,554,880.50</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">ACHN</td><td class=" colIssueName col2">ACHILLION PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.06</td><td class=" colNotionalValue col8">5,544,554.50</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">CRBP</td><td class=" colIssueName col2">CORBUS PHARMACEUTICALS HOLDINGS IN</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.05</td><td class=" colNotionalValue col8">5,443,182.15</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">CLDX</td><td class=" colIssueName col2">CELLDEX THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.05</td><td class=" colNotionalValue col8">5,428,771.39</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">MRSN</td><td class=" colIssueName col2">MERSANA THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.05</td><td class=" colNotionalValue col8">5,426,138.94</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">CERS</td><td class=" colIssueName col2">CERUS CORP</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.05</td><td class=" colNotionalValue col8">5,379,061.32</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">ADAP</td><td class=" colIssueName col2">ADAPTIMMUNE THERAPEUTICS ADR REPRE</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.05</td><td class=" colNotionalValue col8">5,347,331.76</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">SNNA</td><td class=" colIssueName col2">SIENNA BIOPHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.05</td><td class=" colNotionalValue col8">5,130,842.43</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">INO</td><td class=" colIssueName col2">INOVIO PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.05</td><td class=" colNotionalValue col8">5,096,948.58</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">NK</td><td class=" colIssueName col2">NANTKWEST INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.05</td><td class=" colNotionalValue col8">5,005,109.34</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">CORI</td><td class=" colIssueName col2">CORIUM INTERNATIONAL INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.05</td><td class=" colNotionalValue col8">4,814,262.18</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">MRNS</td><td class=" colIssueName col2">MARINUS PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.05</td><td class=" colNotionalValue col8">4,747,189.80</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">AVDL</td><td class=" colIssueName col2">AVADEL PHARMACEUTICALS ADR PLC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.05</td><td class=" colNotionalValue col8">4,591,629.87</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">NH</td><td class=" colIssueName col2">NANTHEALTH INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.05</td><td class=" colNotionalValue col8">4,578,585.30</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">TTPH</td><td class=" colIssueName col2">TETRAPHASE PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.04</td><td class=" colNotionalValue col8">4,440,915.20</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">ARDX</td><td class=" colIssueName col2">ARDELYX INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.04</td><td class=" colNotionalValue col8">4,309,419.45</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">PACB</td><td class=" colIssueName col2">PACIFIC BIOSCIENCES OF CALIFORNIA</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.04</td><td class=" colNotionalValue col8">4,279,359.60</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">NLNK</td><td class=" colIssueName col2">NEWLINK GENETICS CORP</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.04</td><td class=" colNotionalValue col8">4,177,631.85</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">CALA</td><td class=" colIssueName col2">CALITHERA BIOSCIENCES INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.04</td><td class=" colNotionalValue col8">4,165,586.10</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">ARWR</td><td class=" colIssueName col2">ARROWHEAD PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.04</td><td class=" colNotionalValue col8">4,047,657.17</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">GERN</td><td class=" colIssueName col2">GERON CORP</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.04</td><td class=" colNotionalValue col8">3,973,248.42</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">PETQ</td><td class=" colIssueName col2">PETIQ INC CLASS A</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.04</td><td class=" colNotionalValue col8">3,961,590.00</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">CCXI</td><td class=" colIssueName col2">CHEMOCENTRYX INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.04</td><td class=" colNotionalValue col8">3,929,813.13</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">NEOS</td><td class=" colIssueName col2">NEOS THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.04</td><td class=" colNotionalValue col8">3,893,952.40</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">MNKD</td><td class=" colIssueName col2">MANNKIND CORP</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.04</td><td class=" colNotionalValue col8">3,873,489.20</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">BLCM</td><td class=" colIssueName col2">BELLICUM PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.04</td><td class=" colNotionalValue col8">3,813,262.20</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">ABUS</td><td class=" colIssueName col2">ARBUTUS BIOPHARMA CORP</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.04</td><td class=" colNotionalValue col8">3,677,810.40</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">CLLS</td><td class=" colIssueName col2">CELLECTIS ADR REPRESENTING SA</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.03</td><td class=" colNotionalValue col8">3,392,062.74</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">NERV</td><td class=" colIssueName col2">MINERVA NEUROSCIENCES INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.03</td><td class=" colNotionalValue col8">3,354,336.70</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">AUPH</td><td class=" colIssueName col2">AURINIA PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.03</td><td class=" colNotionalValue col8">3,353,049.90</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">VTL</td><td class=" colIssueName col2">VITAL THERAPIES INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.03</td><td class=" colNotionalValue col8">3,275,407.00</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">FOMX</td><td class=" colIssueName col2">FOAMIX PHARMACEUTICALS LTD</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.03</td><td class=" colNotionalValue col8">3,255,854.36</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">SBBP</td><td class=" colIssueName col2">STRONGBRIDGE BIOPHARMA</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.03</td><td class=" colNotionalValue col8">3,242,858.80</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">PETX</td><td class=" colIssueName col2">ARATANA THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.03</td><td class=" colNotionalValue col8">3,147,877.89</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">CRVS</td><td class=" colIssueName col2">CORVUS PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.03</td><td class=" colNotionalValue col8">2,995,820.20</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">CMRX</td><td class=" colIssueName col2">CHIMERIX INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.03</td><td class=" colNotionalValue col8">2,982,999.46</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">VCYT</td><td class=" colIssueName col2">VERACYTE INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.03</td><td class=" colNotionalValue col8">2,940,166.40</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">TOCA</td><td class=" colIssueName col2">TOCAGEN INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.03</td><td class=" colNotionalValue col8">2,903,323.26</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">SNDX</td><td class=" colIssueName col2">SYNDAX PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.03</td><td class=" colNotionalValue col8">2,853,860.55</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">ECYT</td><td class=" colIssueName col2">ENDOCYTE INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.03</td><td class=" colNotionalValue col8">2,843,332.80</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">NSTG</td><td class=" colIssueName col2">NANOSTRING TECHNOLOGIES INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.03</td><td class=" colNotionalValue col8">2,644,005.36</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">TLGT</td><td class=" colIssueName col2">TELIGENT INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.03</td><td class=" colNotionalValue col8">2,613,993.88</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">CASC</td><td class=" colIssueName col2">CASCADIAN THERAPEUTICS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.03</td><td class=" colNotionalValue col8">2,613,431.14</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">RARX</td><td class=" colIssueName col2">RA PHARMACEUTICALS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.03</td><td class=" colNotionalValue col8">2,586,517.78</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">CRIS</td><td class=" colIssueName col2">CURIS INC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.02</td><td class=" colNotionalValue col8">1,632,154.44</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="odd"><td class=" colTicker col1">NBRV</td><td class=" colIssueName col2">NABRIVA THERAPEUTICS PLC</td><td class=" colAssetClass col3">Equity</td><td class=" colHoldingPercent col4">0.01</td><td class=" colNotionalValue col8">989,081.25</td><td class=" colSectorName col9">Health Care</td></tr><tr role="row" class="even"><td class=" colTicker col1">USD</td><td class=" colIssueName col2">USD CASH</td><td class=" colAssetClass col3">Cash</td><td class=" colHoldingPercent col4">-0.10</td><td class=" colNotionalValue col8">-9,890,506.06</td><td class=" colSectorName col9">Cash and/or Derivatives</td></tr></tbody>